CoChat

Haemoconcentration, Renal Function, and Post-Discharge Outcomes Among Patients Hospitalized for Heart Failure with Reduced Ejection Fraction: Insights from the EVEREST Trial

Open access
Greene, Stephen J., Gheorghiade, Mihai, Vaduganathan, Muthiah, Ambrosy, Andrew P., Mentz, Robert J., Subacius, Haris, Maggioni, Aldo P., Nodari, Savina, Konstam, Marvin A., Butler, Javed, Filippatos, Gerasimos · 2013 · European Journal of Heart Failure
Cited by 140

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Aims: Haemoconcentration has been studied as a marker of decongestion in patients with hospitalization for heart failure (HHF). We describe the relationship between haemoconcentration, worsening renal function, post-discharge outcomes, and clinical and laboratory markers of congestion in a large multinational cohort of patients with HHF. Methods and results: In 1684 patients with HHF with ejection fraction (EF) ≤40% assigned to the placebo arm of the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) trial, absolute in-hospital haematocrit change was calculated as the change between baseline and discharge or day 7 (whichever occurred first). Patient characteristics, changes in renal function, and outcomes over a median follow-up of 9.9 months were compared by in-hospital haematocrit change. Overall, 26% of patients had evidence of haemoconcentration (i.e. ≥3% absolute increase in haematocrit). Patients with greater increases in haematocrit tended to have better baseline renal function. Haemoconcentration correlated with greater risk of in-hospital worsening renal function, but renal parameters generally returned to baseline within 4 weeks post-discharge. Patients with haemoconcentration were less likely to have clinical congestion at discharge, and experienced greater in-hospital decreases in body weight and natriuretic peptide levels. After adjustment for baseline clinical risk factors, every 5% increase of in-hospital haematocrit change was associated with a decreased risk of all-cause death [hazard ratio (HR) 0.81, 95% confidence interval (CI) 0.70–0.95]. Haematocrit change was also associated with decreased cardiovascular mortality or heart failure (HF) hospitalization at ≤100 days post-randomization (HR 0.73, 95% CI 0.71–0.76). Conclusion: In this large cohort of patients with HHF with reduced EF, haemoconcentration was associated with greater improvements in congestion and decreased mortality and HF re-hospitalization despite an increased risk of in-hospital worsening renal function.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurjhf/hft110

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 140

Metadata

Authors
Greene, S. J., Gheorghiade, M., Vaduganathan, M., Ambrosy, A. P., Mentz, R. J., Subacius, H., Maggioni, A. P., Nodari, S., Konstam, M. A., Butler, J., & Filippatos, G.
Venue
European Journal of Heart Failure
Published
2013-12-01
Volume
15
Issue
12
Pages
1401-1411
ISSN
  • 1388-9842 (ISSN-L)
  • 1879-0844
OpenAlex
W2005157649
Cited by
140
References
4
FWCI
7.20
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Haemoconcentration, Renal Function, and Post-Discharge Outcomes Among Patients Hospitalized for Heart Failure with Reduced Ejection Fraction: Insights from the EVEREST Trial. https://app.cochat.ai/papers/10.1093/eurjhf/hft110
The paper
Greene, S. J., Gheorghiade, M., Vaduganathan, M., Ambrosy, A. P., Mentz, R. J., Subacius, H., Maggioni, A. P., Nodari, S., Konstam, M. A., Butler, J., & Filippatos, G. (2013). Haemoconcentration, Renal Function, and Post-Discharge Outcomes Among Patients Hospitalized for Heart Failure with Reduced Ejection Fraction: Insights from the EVEREST Trial. European Journal of Heart Failure. https://doi.org/10.1093/eurjhf/hft110

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.